PharmaTimesNews & Politicsnews

AstraZeneca wins US approval for first‑in‑class Baxfendy in hypertension

Tuesday, May 19, 2026John PinchingView original

Baxdrostat delivers clinically meaningful blood pressure reductions in phase 3 BaxHTN trial

Read the full article on the original site.